218 related articles for article (PubMed ID: 29989856)
21. Second malignant neoplasms in testicular cancer survivors.
Fung C; Fossa SD; Beard CJ; Travis LB
J Natl Compr Canc Netw; 2012 Apr; 10(4):545-56. PubMed ID: 22491051
[TBL] [Abstract][Full Text] [Related]
22. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
23. Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors.
Milano MT; Dinh PC; Yang H; Zaid MA; Fossa SD; Feldman DR; Monahan PO; Travis LB; Fung C
JNCI Cancer Spectr; 2020 Jun; 4(3):pkaa017. PubMed ID: 32455335
[TBL] [Abstract][Full Text] [Related]
24. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
25. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
26. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
27. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
28. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
29. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
30. Secondary neoplasms following treatment of malignant germ cell tumors.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1993 Sep; 11(9):1703-9. PubMed ID: 8394879
[TBL] [Abstract][Full Text] [Related]
31. Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.
Casagranda L; Oriol M; Freycon F; Frappaz D; Bertrand Y; Bergeron C; Plantaz D; Stephan JL; Freycon C; Gomez F; Berger C; Trombert-Paviot B
Pediatr Hematol Oncol; 2016 Sep; 33(6):371-382. PubMed ID: 27687523
[TBL] [Abstract][Full Text] [Related]
32. Risk of second malignant neoplasms in women and girls with germ cell tumors.
Liao Z; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
Ann Oncol; 2017 Feb; 28(2):329-332. PubMed ID: 27864217
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival.
Patel HD; Srivastava A; Alam R; Joice GA; Schwen ZR; Semerjian A; Allaf ME; Pierorazio PM
Urol Oncol; 2017 Oct; 35(10):606.e1-606.e7. PubMed ID: 28712791
[TBL] [Abstract][Full Text] [Related]
34. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
35. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract][Full Text] [Related]
36. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
[TBL] [Abstract][Full Text] [Related]
37. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
[TBL] [Abstract][Full Text] [Related]
38. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
40. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]